Latest News about LEXX
Recent news which mentions LEXX
12 Health Care Stocks Moving In Friday's After-Market Session
January 07, 2022
From Benzinga
Lexaria Bioscience Increases Investor Visibility with SRAX
January 07, 2022
From Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
January 06, 2022
From Benzinga
Lexaria Bioscience Announces Approval from Independent Review for DehydraTECH-CBD Study
December 30, 2021
Tickers
LEXX
From Benzinga
Lexaria Bioscience Expects Study Results to Show Patented Tech's Value in Treating Hypertension
December 28, 2021
Tickers
LEXX
From Benzinga
Lexaria Bioscience Announces Major Discovery; Increasing Effectiveness of Orally Administered CBD
December 23, 2021
Tickers
LEXX
From Benzinga
From Benzinga
Lexaria Bioscience Committed to Innovation and Improving Quality of Life
December 15, 2021
Tickers
LEXX
From Benzinga
Lexaria's Upcoming R&D Programs Targeting Global Markets Exceeding $160B
December 13, 2021
Tickers
LEXX
From Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
December 10, 2021
From Benzinga
52 Biggest Movers From Yesterday
December 09, 2021
From Benzinga
Lexaria Bioscience Featured in Virtual Coverage of Benzinga's Small Cap Conference
December 08, 2021
Tickers
LEXX
From Benzinga
35 Stocks Moving In Wednesday's Mid-Day Session
December 08, 2021
From Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
December 08, 2021
From Benzinga
Lexaria Bioscience Embarking on Potentially Pivotal Study to Evaluate DehydraTECH-CBD
December 03, 2021
Tickers
LEXX
From Benzinga
Lexaria's DehydraTECH(TM) Demonstrates 10-20X Faster Nicotine Delivery in Recent Study
November 29, 2021
From Benzinga
Lexaria Bioscience's DehydraTECH(TM) Drug Delivery Tech Finding Multiple Applications
November 24, 2021
From Benzinga
Lexaria Bioscience Announces 2022 DehydraTECH(TM) R&D Programs
November 18, 2021
From Benzinga
Lexaria Expands 2022 R&D Programs to Evaluate Alzheimer's, Diabetes
November 11, 2021
Tickers
LEXX
From Benzinga
Lexaria Bioscience Corp. Commences New Animal Study Evaluating Patented DehydraTECH(TM) Technology's Efficacy in Reducing/Inhibiting Seizure Activity
November 04, 2021
From Benzinga
Lexaria Bioscience Corp. to Expand Hypertension Clinical Program Through Most Ambitious Study to Date
November 03, 2021
Tickers
LEXX
From Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
November 03, 2021
From Benzinga
Lexaria Bioscience Corp. Begins R&D Program Comparing DehydraTECH-CBD with Generic CBD, Epidiolex
November 02, 2021
Tickers
LEXX
From Benzinga
Lexaria Announces DehydraTECH-CBD Versus Prescription CBD Program In Treating Seizures
November 01, 2021
From Benzinga
Lexaria Bioscience Corp.'s DehydraTECH(TM) Addresses the Needs of Medical THC Users
October 26, 2021
From Benzinga
Lexaria Starts IND-Enabling Program For DehydraTECH-CBD For Hypertension
September 08, 2021
Tickers
LEXX
From Benzinga
From InvestorPlace
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.